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Abstract (80 words) 
Radiation therapy is rapidly evolving toward the delivery of higher dose rates to improve cancer 
treatment. In vitro experiments were performed to investigate the response of 9L and MCF-7 cancer cell 
lines, exposed to 10 MV X-ray radiations. Up to 8 Gy was delivered at a dose-rate of 50 cGy/min 
compared to 5 Gy/min. The data obtained emphasizes the importance of taking into account not only the 
physical, but also the radiobiological parameters, when planning a particular cancer treatment. 
 
Keywords: Inverse dose-rate, megavoltage, radiation therapy 
1. Introduction 
Radiation therapy (RT) is an important modality for many cancer treatments, with over 50% of 
cancer patients receiving some form of RT as part of their cancer management plan. The ongoing 
challenge in RT treatment is the controlled delivery of a lethal dose to the tumor whilst minimizing 
damage to the surrounding normal tissue. Modern radiotherapy techniques such as intensity 
modulation radiation therapy (IMRT), intensity modulated arc therapy (IMAT) or volumetric-
modulated arc therapy (VMAT), and stereotactic radiotherapy (SRT) (Benedict et al. 2001; Siochi 
1999; Tubiana et al. 2000) have improved local tumor control through better precision of the radiation 
dose delivered. These technologies consequently often deliver more complex treatment fields than 
conventional techniques.  
Clinically, IMRT has become an important modality and it has been widely used in 
radiotherapy for over 15 years. The capabilities of IMRT have been extensively described in the 
literature in physical term advantages, such as target coverage conformity, better dose uniformity, and 
sparing the adjacent normal tissue. These make IMRT superior to conventional or three-dimensional 
conformal external radiotherapy (3D-CRT) (Cheung 2006; Intensity Modulated Radiation Therapy 
Collaborative Working Group 2001). However, in IMRT, an increased number of monitor units 
(MU’s) are required, and thus IMRT (beam-on time) generally involves a longer dose delivery time 
than conventional RT. The radiobiological advantages of IMRT have been extensively debated in the 
literature (Fowler et al. 2004; Ling et al. 2010; Lohse et al. 2011; Moiseenko et al. 2007; Mu et al. 
2003; Sorensen et al. 2011; Wang et al. 2003). The suspicion that IMRT could decrease tumor control 
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due to the increase in the overall treatment time does not have any clinical evidence, and is offset by 
the advantages linked to the better conformation of physical doses to the target volumes and therefore 
better sparing of critical organs.  
Improvement in clinical outcomes can be achieved by reducing patient intra fraction 
movements. Recent technical developments have therefore focused on increasing the clinical dose rates 
to minimize the effect of such movements. Increasing the dose rate also has the added benefit of 
reducing the overall patient treatment time thus allowing an increase in patient throughput. One recent 
development is the removal of flattening filters in the linear accelerator heads (flattening filter free 
(FFF) LINAC configuration), which has proven to be particularly beneficial for IMRT and SRT (Fu et 
al. 2004; Kragl et al. 2009; Stathakis et al. 2009). The absence of the flattening filter, leading to a 
significant decrease in the number of MU’s for a given photon treatment delivery, has been reported in 
the literature for both Varian (energies 6 MV and 18 MV) (Stathakis et al. 2009) and Elekta (energies 
6 MV and 10 MV) (Kragl et al. 2009) clinical linear accelerators. It is thus important to, and would be 
hazardous not to, investigate the biological effectiveness of physical radiation doses delivered with 
differing dose rates.  
  Some recent data published related to this has emphasized the radiobiological effect of a high 
instantaneous dose rate and indicated that there is no effect of the instantaneous dose rate of FFF 
LINACs on clonogenic cell survival (Sorensen et al. 2011). Other data however e.g. Lohse et al. 
(2011), shows that the radiobiological effect of the FFF beam is dependent on the dose per pulse and 
suggests that this might become a crucial factor that influences cancer cell survival. Ling et al. (2010) 
reviewed the dose rate effect in external beam radiotherapy and concluded that it is the overall beam-
on time that determines the tumor cell survival, not the average dose-rate of the linear accelerator 
(LINAC) nor the instantaneous dose-rates within LINAC pulses. In this work, we are primarily focused 
on the overall time of irradiation and its influence on the survival of two cell lines with significantly 
different radiosensitivities. 
Dose-rate sparing is usually known to involve a decreased biological response to radiation 
exposure at a low dose rate compared to a high dose rate, as theoretically predicted by Lajtha et al. 
(1961). On the contrary, Mitchell et al. first identified the decrease in survival of HeLa cells irradiated 
at a low dose rate of 37 cGy/h compared with a high dose rate of 1.54 Gy/h and this was referred to as 
the “inverse dose-rate effect” (Mitchell et al. 1977; Mitchell et al. 1979b). Similar studies by Furre et 
al. (1999), also observed an inverse dose-rate effect on NHIK 3025 cells. These data suggest that for 
some cell lines, a monotonic increase in dose-rate does not produce a similar increase in cell killing. 
Moreover, in some specific cell lines, increasing the dose rate actually decreases the cell killing 
effectiveness.  
In this article we report on results of in vitro experiments in which the biological effect of 
differing dose-rates for 10 MV X-ray irradiations delivery from a LINAC has been assessed by colony 
forming assay. The dose is delivered using clinical dose rates of 50 cGy/min compared to a 10-fold 
higher dose rate of 5 Gy/min. 9L and MCF-7 cell lines were used because they represent a good pre-
clinical model of brain and breast tumor tissues respectively. Their intrinsic radiosensitivity is 
different, with 9L being considered to be more radiation resistant than the MCF-7. To our knowledge, 
this is the first time that the biological effectiveness of 10 MV X-ray radiation doses on 9L and MCF-7 
cell lines has been investigated. The significance in the findings of this study are discussed with regard 
to observations on the radiosensitivity of the 9L and MCF-7 cells, concepts of radiobiology, and 
potential implications for new methods of dose delivery (IMRT, IMAT, VMAT, etc.). 
 
2. Material and Methods 
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2.1. Cell lines 
 
9L, an adherent, fibroblast-like, radio-resistant rat gliosarcoma cell line derived from N-
nitrosomethylurea-induced tumor was obtained from the European Collection of Cell Cultures 
(ECACC). MCF-7 is an adherent, epithelial-like, radiosensitive breast adenocarcinoma cell line 
established from a 69-year-old female (American Type Culture Collection – ATCC). Both cell lines 
were tested routinely for mycoplasma contamination.  Cells were maintained in exponential growth in 
DMEM (Invitrogen, AU) with L-Glutamine and supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin (Pen Strep) at 37C in a humidified incubator with 5% CO2 in air.  
 
2.2. Irradiation procedures 
 
The irradiations were performed at the radiation oncology department in the Prince of Wales hospital, 
Randwick, Australia, using an Axesse Elekta LINAC with beam modulator (Elekta AB, 
Kungstensgatan, Stockholm, Sweden) operated at energy of 10 MV. Single exposure with doses of 1, 
2, 3, 5, and 8 Gy were delivered at dose rates of 50 cGy/min and 5 Gy/min.  
 
Experiments were carried out with confluent cultures grown as monolayer in 12.5 cm
2
 cell culture 
flasks with a vented screw cap (BD Falcon) containing 5 mL of DMEM medium and 30 mL of Hanks’ 
balanced salt solution (HBSS). The cells flasks were placed vertically facing the beam and were 
positioned at a depth of 2.2 cm in solid water to match the Dmax depth of the 10 MV photon field. An 
additional thickness of 10 cm of solid water was placed behind the flask to assure adequate scattering 
conditions. To maintain electronic equilibrium conditions within the flasks during the irradiation, the 
flasks were also surrounded by solid water slabs. The irradiation field size used for all experiments was 
10.4  10.4 cm
2
 and the source-to-surface distance (SSD) was 100 cm. Figure 1 shows a schematic 
diagram of the setup for cellular irradiation. Cell culture flasks were irradiated at room temperature. 
Unirradiated control samples were kept at room temperature in the control room (i.e at the same 
condition as the irradiated samples – full of HBSS buffer and placed vertically) while the other samples 
were irradiated in the LINAC bunker.  
 
 
2.3. Clonogenic survival  
 
Cell survival was measured by the colony-forming assay, i.e. the ability of a single cell to form 
colonies in vitro (Puck et al. 1956). The method used in this study was derived from previous work 
(Oktaria et al. 2015). Both the control and irradiated cells were plated immediately after the irradiation 
experiments. The medium was removed and the confluent cells were washed gently with DPBS (Ca
2+
 
and Mg
2+ 
free), then detached using Trypsin-EDTA. The disassociated cells were counted with a 
haemocytometer and seeded at low densities to achieve approximately 100 colonies after fifteen 
doubling times into 100-mm tissue culture dishes (BD Falcon) containing 10 mL of complete cell 
medium (i.e. DMEM containing L-Glutamine and supplemented with 10% (v/v) FBS and 1% (v/v) 
PenStrep). Depending on the prescribed dose, each experiment involved a maximum of three cells 
densities with triplicate dishes for each density. The numbers of cells plated per petri dish were 
determined by preliminary experiments designed in order to determine the radiosensitivity of the cell 
lines. The cells in petri dishes were then incubated to allow colonies to form at 37C humidified 5% 
(v/v) CO2 cell culture incubator (HERACELL 150i). After fifteen doubling times, the colonies were 
fixed and stained with a mixture solution of 25% (v/v) crystal violet (Sigma-Aldrich) and 75% (v/v) 
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10 cm thick of solid 
water 
 
ethanol for 5 minutes, washed, and air-dried. Only the numbers of colonies containing more than 50 
cells were counted as observed by microscope.  
 
 
 
 
 
 
   
 
 
 
Fig 1. Experimental setup for cellular irradiation. 
 
 
2.4. Cell cycle analysis by flow cytometry 
 
Measurements of the cell cycle distribution were performed by flow cytometric analysis using 
propidium iodide (PI) staining. The method used was derived from previous work (Oktaria et al. 2015; 
Vine et al. 2007). Cells (2.0 x 10
6
) were centrifuged at 1500 rpm for 5 min at 4C and washed twice 
with cold phosphate buffer solution (PBS) (Ca
2+
 and Mg
2+ 
free) then fixed by drop wise addition of 
1mL ice-cold ethanol (70%) and stored at -20C for up to 7 days before DNA analysis. The ethanol 
was then removed via a centrifuge process, washed twice with cold PBS. The cells were then stained 
with a solution containing 40 g/mL PI, 100 g/mL RNase A, and PBS (pH 7.4) at 37C for 1 hour. 
The stained nuclei were analyzed for DNA-PI fluorescence using a Becton Dickinson fluorescence-
activated cell sorting (FACS) flow cytometer (BD LSR II; BD Biosciences, USA). A minimum of 
10,000 single cell events was analyzed for each sample in each experiment and at least three 
independent experiments was performed.  
 
2.5. Data analysis 
 
2.5.1. Plating efficiency and surviving fraction. The plating efficiency (PE) was calculated as the 
number of surviving colonies divided by the number of cells seeded and the surviving fraction (SF) is 
the cell survival fraction at dose, D is detailed in (Franken et al. 2006) The radiation dose-survival 
curves were generated by plotting the SF as a function of the dose delivered on a semi-logarithmic 
scale. The SF expressed as a function of dose (D) curves were fitted using IgorPro software using the 
linear quadratic (LQ) model where  [Gy
-1
] and  [Gy
-2
] are the 
radiosensitivity parameters (Chadwick et al. 1973; Curtis 1986; Fertil et al. 1981; 1985; Franken et al. 
2013). 
 
2.2 cm thick of solid water 
 
T12.5cm
2
 flask (monolayer cells with 
5mL cell medium + 30mL buffer) – side 
view 
SSD100 
(10.4  10.4cm
2
 field size) 
10 MV x-ray beam 
Table couch 
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2.5.2. Flow cytometry data. Cell doublets and aggregates were gated out using a two-parameter 
histogram of FL2-Area versus FL2-Height. The resulting DNA distribution was then analyzed on the 
basis of histograms using FACSDiva software (V6.1.3; BD Biosciences, USA) for the proportion of 
cells in G0/G1, S and G2/M phases of cell cycle. All data were stored by the computer system in a flow 
cytometer standard (FCS) format. 
 
3. Results 
The cell survival curves of the 9L and MCF-7 cells after irradiation with 10 MV X-rays at a dose-rate 
of 5 Gy/min are plotted on the same graph to allow comparison of the relative radiosensitivities of the 
two cell lines (Figure 2). From the graph it can be seen that 9L cells are about 2.2 times more resistant 
than MCF-7 cells. The 10% survival doses (D10) in 9L and MCF-7 are 8 Gy and 3.7 Gy, respectively. 
Table 1 presents the radiobiological parameters and indicates that the 9L cell line is more radioresistant 
than MCF-7. These findings are consistent with values published in the literature, which are 
=0.24 Gy
-1
; =0.029 Gy
-2
 for glioblastomas and =0.45 Gy
-1
 and =0.039 Gy
-2
 for adenocarcinoma 
(Malaise et al. 1987).  
  
 
Fig 2. Survival curves of 9L and MCF-7 irradiated at a dose-rate of 5 Gy/min. The data were fitted to 
the linear-quadratic model. The error bars represent the means   SEM of at least three independent 
experiments. 
 
The results for the 10 MV X-rays irradiation experiment at a dose-rate of 50 cGy/min compared to 
5 Gy/min on 9L and MCF-7 cells are shown in Figure 3. The reduction of dose-rate appears to have no 
effect on clonogenic survival of 9L cells (Figure 3A). However, with MCF-7 cells, the lower dose-rate 
irradiation results in a decreased clonogenic survival (Figure 3B). Analysis of the data using the LQ 
model is shown in table 1 and reveals that the  value for MCF-7 cells irradiated at 50 cGy/min 
(0.83 0.01 Gy-1) is larger than the corresponding value when irradiated at 5 Gy/min (0.47 0.03 Gy-1). 
Hence, the change in the efficacy of treatments was found, as measured quantitatively by a significant 
reduction of 20% in the necessary absorbed radiation dose in order to achieve the same 10% cell-
surviving fraction. The relative biological effectiveness (RBE) was estimated from and  parameters 
as the ratio of dose of the reference radiation (dose rate of 5 Gy/min) to that of the test radiation (dose 
rate of 50 cGy/min) required to reduce the cell survival to 37%. The calculated RBE values were 1 and 
1.5 for 9L and MCF-7, respectively. 
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In an effort to evaluate whether the observed inverse dose-rate effect is linked to the proportion of cells 
in radioresistant and sensitive phases of the cell cycle, FACS analysis was performed. Under 
asynchronous confluent conditions, the percentages of cells in G0/G1, S, and G2/M in both cell lines are 
summarized in Table 2.  
(A)           (B) 
   
 
 
Fig 3. Survival curves of 9L cells (Panel A) and MCF-7 cells (Panel B) irradiated at dose rate of 50 
cGy/min vs. dose rate 5 Gy/min. The data were fitted to the linear quadratic model. Each data point 
represents the means   SEM of at least three independent experiments (each triplicate). 
 
 
4. Discussions 
 
Clonogenic assay was used to determine cell reproductive death after treatment with ionizing radiation 
as described by Puck and Markus (1956) who obtained the first X-ray radiation dose survival curve for 
irradiated HeLa cells in culture. Since their pioneering work, the intrinsic radiosensitivity of cells 
derived from human tumors has been the subject of many studies. In the present study, this assay was 
performed to measure the capability of each cell line to proliferate and produce colonies after 
irradiation. This relationship can be modeled by a linear-quadratic function of radiation dose.  
As is generally true for most glioma cell lines, the 9L cell line is aggressive and less 
radiosensitive than other rat tumor cell lines (Bencokova et al. 2008; Henderson et al. 1981). It is the 
most widely used of all rat brain tumor models for research (Barth 1998) as well as for preclinical 
model used in brain radiotherapy (Vinchon-Petit et al. 2010); it has been utilized in such experiments 
for more than 30 years (Kimler 1994). The MCF-7 cell line represents a well-adopted pre-clinical 
model of breast tumor tissue. It has provided the basis of many breast cancer biology studies (Tutt et 
al. 2006) and is relatively more radiosensitive (Matthews et al. 1989).  
In the present study, we observed no difference between low dose rate 50 cGy/min and high 
5 Gy/min dose rate survival curves of the 9L cell line (Figure 3A). Interestingly, we observed an 
inverse dose rate effect for the MCF-7 cells (Figure 3B), where the lower dose rate of 50 cGy/min 
induced a 50% increase in RBE compared to that for the reference 5 Gy/min dose rate. The inverse 
dose rate effect is complemented with a linearization of the cell survival curve when the lower dose 
rate experiment at 50 cGy/min is performed. The results observed above suggest that the optimum dose 
rate radiotherapy can be significantly different depending on the tumor cells type. 
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Several studies have shown that by decreasing the radiation dose rate, recovery processes are 
allowed to take place during irradiation (i.e. within the first few hours), which usually leads to a 
reduced biological effect (Hall 1972; Steel 1989). This traditional key characteristic of the dose-rate 
effect appears to be inversed in this study. The mechanisms underlying the cause of the inverse nature 
of the dose-rate effect are not well understood, but may be due to several reasons. Possible 
explanations for this finding are that the effect is dependent on the intrinsic radiosensitivity that varies 
along the cell cycle at the time of irradiation (Ling et al. 1995), cell type (Fertil and Malaise 1981), 
doubling time (Mitchell et al. 1979a), cell age (Biade et al. 1997) and more clinically, the histology 
type (Ramsay et al. 1992). Numerous studies have shown that the X-ray induced deficiency in DNA 
synthesis depends on the cell cycle phase of cells at the time of irradiation (Denekamp 1986; Griffiths 
et al. 1975; Rowley et al. 1985). In this study, the underlying mechanism leading to the 20% difference 
in the efficacy between the treatments was (and still is) unclear. However these positive data warranted 
the further exploration into identifying a mechanism that manifested as a dose-rate effect on the 
biological effectiveness of megavoltage x-ray radiation doses on one of the cell lines investigated. 
Radiation sensitivity, expressed as loss of reproductive ability, depends on the cell cycle phase 
in which the cells are exposed. The variation in the cell cycle response to ionizing radiation is believed 
to be due to the intrinsic radiosensitivity of some human tumor cells (Biade et al. 1997). A lower dose 
rate would then be expected to be more effective if a phase of the cell cycle (i.e. G2/M-phase) was 
correlated with the radiosensitivity (Knox et al. 1993; Marples 2004; Wilson 2004). Numerous studies 
have found that plateau-phase cultures are generally more radiosensitive than exponentially growing 
cells. On the contrary, some studies have observed the development of radioresistance in plateau phase 
with a V79 cells (Durand et al. 1973) and 9L cells (Kimler et al. 1982; Mendonca et al. 1989). 
However, this condition is minimized in this study as our experiments were carried out with confluent 
cultures, where the cell number remained constant throughout the irradiation.  
The flow cytometry experiments performed as part of this work evaluated whether the 
observed inverse dose-rate effect is linked to the differences in the intrinsic radiosensitivity between 
these two cell lines. FACS analysis was performed to analyze the cell cycle distribution and DNA 
content, indicated that the proportions of cells in the same phase were similar for the two cell lines. 
Cells are most radiosensitive in phases G2/M, have intermediate radiosensitivity in G0/G1 and are most 
radioresistant at the S-phase (Tubiana M et al. 1990). It is reasonable then to consider that the in vitro 
radiosensitivity of a cell line may be influenced by the proportion of cells in the different phases of the 
cell cycle. Our flow cytometry results indicate that the phase distribution of the cells most likely does 
not play a significant role in the observed differences in the radiation sensitivities of the two cell lines. 
This study has potential implications for external radiation delivery techniques, where the 
dose-rate is greatly increased. It is hypothesized that in vitro cellular radiosensitivity is correlated with 
in vivo tissue response (Deacon et al. 1984). For instance, the  parameter predicts best for intrinsic 
radiosensitivity of tumor cells irradiated at a dose of 2 Gy (SF2) (Fertil and Malaise 1981; Malaise et 
al. 1987). The clinical implementation of different dose-response parameters on biologically optimized 
IMRT in breast cancer has been studied by Ferreira et al. (2008), which suggest that it can only be 
maximized by predicting the individual patient radiosensitivity. In general, our study supports the view 
that individualized radiation therapy may significantly increase the benefits for patients with extreme 
radiosensitivity or radioresistance. 
Since no single molecular factor has been identified that is common to all the cancer cell lines 
that can explain their radiation sensitivity to radiation dose-rate, an improved understanding of the 
intrinsic radiosensitivity and damage repair mechanisms should lead to personalized enhanced cancer 
RT treatments. The results presented in this study may contribute to clinically significant 
radiobiological effects as the lower dose-rate induced an increased cell killing in MCF-7 cells. It 
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suggests that some patients with breast cancer would not benefit from the latest technological advances 
and would better benefit from a dose delivery with a lower dose rate (rather than a higher) for a better 
treatment outcome.  
External beam conformal RT techniques such as 3D-CRT, IMRT, and VMAT have been 
reviewed for partial breast irradiation (PBI) treatment (Njeh et al. 2012) and for malignant glioma of 
the brain (Wagner et al. 2009). There are many papers in the literature showing that VMAT, which 
enables the delivery of higher effective clinical dose-rates, can be the most efficient treatment option in 
terms of plan quality and treatment time (better conformal dose distributions with fewer MUs). 
Although VMAT offers the potential to provide improved target coverage and should be favored 
because of the shorter treatment time compared to conventional RT techniques, in vitro experimental 
evidence specific to VMAT and its optimization with the biological response of the tumor is lacking. 
This is in agreement with the observation of McGarry et al. (2012) and Butterworth et al. (2012) by 
addressing the difference in the spatio-temporal dose distribution on cell survival following exposure 
to IMRT and VMAT. Therefore, as highlighted by these authors, there is a need for a definitive 
radiobiological and clinical aspect for VMAT patient selection. Our data demonstrates that for certain 
types of cancer cell lines a higher effective dose rate can lead to decreased radiobiological response 
and therefore a less favorable treatment outcome. Hence, even for radiosensitive patients, a simpler 
treatment technique (i.e 3D-CRT) is sufficient to maximize the outcome. 
 
5. Conclusions 
 
The data presented in this paper have focused on cell survival following the delivery of 10 MV X-rays 
radiation doses at a dose-rate of 50 cGy/min compared to a 10-fold higher dose-rate of 5 Gy/min. To 
date, there has been no literature published that investigates changes in the biological effectiveness of 
10 MV X-ray radiation doses on 9L and MCF-7 cell lines with dose-rate. Our in vitro experiments 
show that the lower dose rate induced a larger effect in cell killing in the MCF-7 cell line. This 
observation emphasizes the importance of taking into account not only the physical dose but also the 
radiobiological responses when planning a particular cancer treatment. This may help clinicians to 
individualize patient treatment decisions so as to maximize the efficacy of treatment and hence the 
clinical outcome of the RT treatment. Moreover, our results may provide important information to 
predict whether all cancer patients, or perhaps only those with particular tumor types, since we have 
demonstrated a variation in radiosensitivity, will benefit from advances in the technologies of RT that 
enable the delivery of X-rays with high dose-rates. Understanding the molecular mechanisms leading 
to cancer cell death induced by X-ray radiation at different dose rate may provide important 
information to assist in the further development of novel treatment options in radiation therapy. Future 
studies that need to be conducted are to evaluate radiation-induced damage and repair process in cancer 
cells due to dose-rate effect. 
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Figure Captions: 
 
Fig 1. Experimental setup for cellular irradiation. 
 
Fig 2. Survival curves of 9L and MCF-7 irradiated at a dose-rate of 5 Gy/min. The data were fitted to 
the linear-quadratic model. The error bars represent the means   SEM of at least three independent 
experiments. 
 
Fig 3. Survival curves of 9L cells (Panel A) and MCF-7 cells (Panel B) irradiated at dose rate of 50 
cGy/min vs. dose rate 5 Gy/min. The data were fitted to the linear quadratic model. Each data point 
represents the means   SEM of at least three independent experiments (each triplicate). 
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Table 1. Summary of cell survival parameters   
 
 
 
 
 
 
 
Table 2. Summary of cell cycle distribution of unirradiated confluent cell populations 
 
 
 
 
 
 
 
 
Highlights 
 We examined the biological effect of differing dose-rates for 10 MV from a LINAC. 
 Cell survival curves were used to determine the and values (radiosensitivity).
 A reduction in dose rate has no effect on the survival curve of 9L cells. 
 A lower dose rate killed more MCF-7 cells. 
 We showed that dose-rate is important in determining the efficacy of IMRT. 
 
 
Cell line Dose rate (Gy/min)  (Gy
-1
)  (Gy
-2
) 
9L 0.5 0.20 0.04 0.013 0.008 
 5 0.20 0.06 0.013 0.008 
MCF-7 0.5 0.83 0.01 0.00 
 5 0.47 0.03 0.040 0.007 
Cell line G0/G1 (%) S (%) G2/M (%) 
9L 64.2 12.6 23.2 
MCF-7 58.7 13.2 28.1 
